MM cells can induce OCs differentiation and osteolytic activity, by modulating release from OBs of the proinflammatory cytokine IL-6 inside the tumor microenvironment; in turn, IL-6 inhibits OBs activity and induces the production of RANKL. The gene discussed is TNFSF11; the disease is Miyoshi myopathy.